Kelly M E, Clay M A, Mistry M J, Hsieh-Li H M, Harmony J A
Developmental Biology Program, University of Cincinnati College of Medicine, Ohio 45267-0575.
Cell Immunol. 1994 Dec;159(2):124-39. doi: 10.1006/cimm.1994.1302.
Apolipoprotein E (apoE), but not apoAI or apoCIII, suppresses mitogen-activated T lymphocyte proliferation, independent of the type of activation signal. Both CD4 and CD8 T cells are inhibited. ApoE inhibits T cell proliferation, in part, by reducing the production of bioactive interleukin 2 (IL2). IL2 activity is reduced by approximately 50-65% in cultures of mitogen-stimulated T cells when apoE is present. ApoE does not significantly alter levels of IL2 mRNA or the mass of secreted IL2 protein, quantitated by enzyme immunoassay. Reduced IL2 activity was not a consequence of induction of IL2 inhibitors in response to apoE or effects of apoE on the bioassay. These results suggest that apoE antagonizes post-translational events in mitogen-activated T lymphocytes that are required for the secretion of a bioactive IL2 protein.
载脂蛋白E(apoE)而非载脂蛋白AI或载脂蛋白CIII可抑制丝裂原激活的T淋巴细胞增殖,且与激活信号类型无关。CD4和CD8 T细胞均受到抑制。ApoE部分通过减少生物活性白细胞介素2(IL2)的产生来抑制T细胞增殖。当存在apoE时,丝裂原刺激的T细胞培养物中IL2活性降低约50 - 65%。ApoE不会显著改变IL2 mRNA水平或通过酶免疫测定法定量的分泌型IL2蛋白量。IL2活性降低并非因对apoE诱导IL2抑制剂或apoE对生物测定的影响所致。这些结果表明,apoE拮抗丝裂原激活的T淋巴细胞中生物活性IL2蛋白分泌所需的翻译后事件。